4//SEC Filing
WAGNER CHARLES F JR 4
Accession 0000875320-26-000002
CIK 0000875320other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:04 PM ET
Size
8.2 KB
Accession
0000875320-26-000002
Insider Transaction Report
Form 4
WAGNER CHARLES F JR
EVP, CO & FO
Transactions
- Exercise/Conversion
Common Stock
2026-01-06$189.38/sh+9,532$1,805,170→ 47,257 total - Sale
Common Stock
2026-01-06$461.00/sh−9,532$4,394,252→ 37,725 total - Exercise/Conversion
Stock Option (Right to Buy)
2026-01-06−9,532→ 0 totalExercise: $189.38Exp: 2029-04-09→ Common Stock (9,532 underlying)
Footnotes (2)
- [F1]Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was entered into on 5/09/2025.
- [F2]Fully vested.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001223348
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 4:04 PM ET
- Size
- 8.2 KB